According to a recent LinkedIn post from Stellaria, the company and the French Alternative Energies and Atomic Energy Commission (CEA) have signed a Letter of Intent for a feasibility study on establishing the “ALPHA” nuclear installation (INB) at the CEA’s Cadarache site. The envisioned facility would host a test model, a fast-spectrum molten-salt liquid-fuel demonstration reactor, and a salt fabrication unit to supply both the prototype and the demo reactor.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post indicates that a specific zone at Cadarache has been identified for assessing the feasibility of the ALPHA INB, suggesting early-stage site selection progress. Stellaria describes this step as a key milestone for its planned critical experiment, Alvin, targeted for 2030 and intended to validate neutronics–thermohydraulic coupling models and calculations.
According to the post, Alvin is positioned as a foundational step toward a larger project termed MegAlvin, which appears to represent the next phase of Stellaria’s technology roadmap. For investors, this progression from LOI to feasibility work may signal a move toward more capital-intensive development, potential future funding needs, and deeper integration within France’s advanced nuclear research ecosystem.
If the ALPHA facility advances beyond feasibility, Stellaria could strengthen its credibility in fast-spectrum molten-salt reactor technology, a niche with long development cycles but potentially significant long-term demand for low-carbon baseload power. The association with the CEA and the Cadarache site may also enhance perceived technical validation, though execution risk, regulatory milestones, and timelines out to 2030 remain key variables for the company’s risk–reward profile.

